NF Trinity Capital’s iShares Biotechnology ETF IBB Stock Holding History

NF Trinity Capital’s Portfolio IBB Stock Details IBB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	$4.83M	Hold	43,200	–	–	0.77%	28
2018 Q4	$4.17M	Hold	43,200	–	–	0.68%	34
2018 Q3	$5.27M	Sell	43,200 -21,750	-33%	-$2.56M	0.7%	36
2018 Q2	$7.13M	Sell	64,950 -43,300	-40%	-$4.63M	0.98%	25
2018 Q1	$11.6M	Sell	108,250 -54,300	-33%	-$6.02M	1.59%	14
2017 Q4	$17.4M	Sell	162,550 -96,500	-37%	-$10.3M	2.26%	12
2017 Q3	$28.8M	Hold	259,050	–	–	4.11%	7
2017 Q2	$26.8M	Sell	259,050 -138,000	-35%	-$13.6M	3.8%	9
2017 Q1	$38.8M	Sell	397,050 -85,500	-18%	-$8.19M	5.25%	8
2016 Q4	$42.7M	Buy	482,550 +35,700	+8%	+$3.25M	6%	7
2016 Q3	$43.1M	Hold	446,850	–	–	4.81%	7
2016 Q2	$38.3M	Buy	446,850 +114,600	+34%	+$10.3M	4.2%	8
2016 Q1	$28.9M	Buy	332,250 +70,950	+27%	+$6.34M	3.5%	9
2015 Q4	$29.5M	Buy	+261,300	New	+$28.4M	3.35%	9

Other funds holding IBB

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

DFO

Duquesne Family Office New York $3.38B AUM 61.92% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Natixis Paris, France $28B AUM 26.79% 1-Year Est. Return

NF Trinity Capital's IBB Position: Q1 2019 in Review

NF Trinity Capital held its iShares Biotechnology ETF (IBB) position steady in Q1 2019 at 43,200 shares worth $4.83M. The position accounts for 0.77% of the portfolio, ranked #28.

NF Trinity Capital first reported a position in IBB in Q4 2015 and has held it in 14 quarters since. The position peaked at $43.1M in Q3 2016. 670 funds tracked by Wall St. Rank hold IBB as of Q1 2019.

NF Trinity Capital held 43,200 shares of iShares Biotechnology ETF worth $4.83M as of Q1 2019.
NF Trinity Capital left its iShares Biotechnology ETF share count unchanged in Q1 2019.
iShares Biotechnology ETF made up 0.77% of NF Trinity Capital's portfolio in Q1 2019, its #28 holding.
NF Trinity Capital first reported a position in iShares Biotechnology ETF in Q4 2015 and has held it in 14 quarters since.
NF Trinity Capital's iShares Biotechnology ETF position peaked at $43.1M in Q3 2016.
670 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q1 2019.

Based on NF Trinity Capital's 13F filing for Q1 2019, filed 10 May 2019.